KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Change in Acquisitions & Divestments: 2011-2025

Historic Change in Acquisitions & Divestments for Sarepta Therapeutics (SRPT) over the last 14 years, with Sep 2025 value amounting to $86.6 million.

  • Sarepta Therapeutics' Change in Acquisitions & Divestments fell 70.94% to $86.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 25.82%. This contributed to the annual value of $2.0 billion for FY2024, which is 7.15% up from last year.
  • Per Sarepta Therapeutics' latest filing, its Change in Acquisitions & Divestments stood at $86.6 million for Q3 2025, which was up 26.12% from $68.6 million recorded in Q2 2025.
  • Sarepta Therapeutics' 5-year Change in Acquisitions & Divestments high stood at $965.1 million for Q4 2024, and its period low was $30.0 million during Q3 2021.
  • Moreover, its 3-year median value for Change in Acquisitions & Divestments was $415.6 million (2023), whereas its average is $369.7 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first soared by 1,231.90% in 2022, then plummeted by 91.47% in 2025.
  • Over the past 5 years, Sarepta Therapeutics' Change in Acquisitions & Divestments (Quarterly) stood at $30.0 million in 2021, then soared by 1,231.90% to $446.5 million in 2022, then increased by 18.30% to $528.2 million in 2023, then surged by 82.71% to $965.1 million in 2024, then plummeted by 70.94% to $86.6 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $86.6 million for Q3 2025, versus $68.6 million for Q2 2025 and $40.8 million for Q1 2025.